

| »áÕ¹Ãû³Æ | 2011Äê¹ú¼ÊTϸ°ûÁܰÍÁöÂÛ̳£¨TLF£© | 
| ²¼Õ¹Ê±¼ä | 2011Äê1ÔÂ26ÈÕ | 
| Õ¹ÀÀʱ¼ä | 2011Äê1ÔÂ27ÈÕ—2011Äê1ÔÂ29ÈÕ | 
| ³·Õ¹Ê±¼ä | 2011Äê1ÔÂ30ÈÕ | 
| »áÕ¹³¡¹Ý | 
             ¾É½ðɽ  | 
        
| Ö÷°ìµ¥Î» | |
| ³Ð°ìµ¥Î» | |
| а쵥λ | |
| »áÕ¹Àà±ð | |
| ËùÔÚµØÇø | 
             ÃÀ¹ú ¾É½ðɽ  | 
        
| »áÕ¹ÃèÊö | 
              This forum will provide a platform for discussion about the classification, epidemiology, prognosis, and pathogenesis of several T-cell lymphoma subtypes. In addition, the latest information on novel agents and treatment approaches will be presented by T-cell lymphoma experts. This meeting is intended for hematologists, oncologists, and other clinicians and scientists with an interest in T-cell lymphoma.  | 
        
| ²ÎÕ¹·ÑÓà | 
             ¡¡  | 
        
| ¹ã¸æ·ÑÓà | 
             ¡¡  | 
        
| Õ¹»áÖÜÆÚ | 
             ÿÄêÒ»½ì  | 
        
| Õ¹»á¹æÄ£ | 
             ¡¡  | 
        
| ×¢ÒâÊÂÏî | 
             
  | 
        
| ÁªÏµ·½Ê½ | 
              ×Éѯµç»°: 8610-66054455  8610-51294800     |